Beverly H. Koller

32.4k total citations · 12 hit papers
206 papers, 25.1k citations indexed

About

Beverly H. Koller is a scholar working on Molecular Biology, Immunology and Pharmacology. According to data from OpenAlex, Beverly H. Koller has authored 206 papers receiving a total of 25.1k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Molecular Biology, 70 papers in Immunology and 36 papers in Pharmacology. Recurrent topics in Beverly H. Koller's work include Inflammatory mediators and NSAID effects (31 papers), Asthma and respiratory diseases (30 papers) and Receptor Mechanisms and Signaling (23 papers). Beverly H. Koller is often cited by papers focused on Inflammatory mediators and NSAID effects (31 papers), Asthma and respiratory diseases (30 papers) and Receptor Mechanisms and Signaling (23 papers). Beverly H. Koller collaborates with scholars based in United States, France and United Kingdom. Beverly H. Koller's co-authors include Thomas M. Coffman, Stephen L. Tilley, Anne M. Latour, Oliver Smithies, John N. Snouwaert, Richard C. Boucher, MyTrang Nguyen, Mary Ellen Moynahan, Maria Jasin and Amy R. Mohn and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Beverly H. Koller

204 papers receiving 24.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production

2008 1.9k citations Beverly H. Koller et al. profile →
The nuclear receptor PXR is a lithocholic acid sensor that protects against liver toxicity

2001 1.1k citations Anne M. Latour, Beverly H. Koller et al. profile →
Brca1 Controls Homology-Directed DNA Repair

1999 970 citations Beverly H. Koller et al. profile →
Mice with Reduced NMDA Receptor Expression Display Behaviors Related to Schizophrenia

1999 849 citations Beverly H. Koller et al. profile →
Altered Cytokine Production in Mice Lacking P2X7Receptors

2001 791 citations Beverly H. Koller, Christopher A. Gabel et al. profile →
Normal Development of Mice Deficient in β ₂ M, MCClass I Proteins, and CD8 ⁺ T Cells

1990 781 citations Beverly H. Koller et al. profile →
An Animal Model for Cystic Fibrosis Made by Gene Targeting

1992 744 citations John N. Snouwaert, Anne M. Latour et al. profile →
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A ₂

2002 667 citations Beverly H. Koller, Thomas M. Coffman et al. profile →
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

1992 652 citations Beverly H. Koller et al. profile →
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

2001 605 citations Thomas M. Coffman, Beverly H. Koller et al. Journal of Clinical Investigation profile →
Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes

2001 589 citations Thomas M. Coffman, Beverly H. Koller et al. Journal of Clinical Investigation profile →
Defective Epithelial Chloride Transport in a Gene-Targeted Mouse Model of Cystic Fibrosis

1992 244 citations Beverly H. Koller et al. profile →

Peers

Countries citing papers authored by Beverly H. Koller

Since Specialization

Citations

This map shows the geographic impact of Beverly H. Koller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly H. Koller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly H. Koller more than expected).

Fields of papers citing papers by Beverly H. Koller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly H. Koller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly H. Koller. The network helps show where Beverly H. Koller may publish in the future.

Co-authorship network of co-authors of Beverly H. Koller

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly H. Koller. A scholar is included among the top collaborators of Beverly H. Koller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly H. Koller. Beverly H. Koller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Target Cell Activation of a Structurally Novel NOD-Like Receptor Pyrin Domain-Containing Protein 3 Inhibitor NT-0796 Enhances Potency 2024 ·Journal of Pharmacology and Experimental Therapeutics ·Pamela J. Smolak, MyTrang Nguyen, (unknown), (unknown), John R. Doedens, Kenneth Schooley, John N. Snouwaert, Mark G. Bock, David Harrison, Alan P. Watt, Beverly H. Koller, Christopher A. Gabel	9
2	Pharmacological Analysis of NLRP3 Inflammasome Inhibitor Sodium [(1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl][(1-methyl-1H-pyrazol-4-yl)({[(2S)-oxolan-2-yl]methyl})sulfamoyl]azanide in Cellular and Mouse Models of Inflammation Provides a Translational Framework 2024 ·ACS Pharmacology & Translational Science ·John R. Doedens, Pamela J. Smolak, MyTrang Nguyen, (unknown), (unknown), Ken Schooley, Andy Billinton, David Harrison, Beverly H. Koller, Alan P. Watt, Christopher A. Gabel	5
3	Initiator cell death event induced by SARS-CoV-2 in the human airway epithelium 2024 ·Science Immunology ·Kaixin Liang, Katherine C. Barnett, Martin Hsu, Wei-Chun Chou, (unknown), (unknown), Yuying Xie, (unknown), Thomas H. Oguin, Kevin M. Vannella, Stephen M. Hewitt, Daniel S. Chertow, Maria Blasi, Gregory D. Sempowski, (unknown), Beverly H. Koller, Deborah J. Lenschow, Scott H. Randell, Jenny P.‐Y. Ting	14
4	Adjuvants restore colistin sensitivity in mouse models of highly colistin-resistant isolates, limiting bacterial proliferation and dissemination 2024 ·Antimicrobial Agents and Chemotherapy ·Beverly H. Koller, Leigh A. Jania, (unknown), William T. Barker, Roberta J. Melander, Christian Melander	2
5	Species-specific NLRP3 regulation and its role in CNS autoinflammatory diseases 2024 ·Cell Reports ·Beverly H. Koller, MyTrang Nguyen, John N. Snouwaert, Christopher A. Gabel, Jenny P.‐Y. Ting	7
6	Metabolism of inorganic arsenic in mice carrying the human AS3MT gene and fed folate deficient or folate supplemented diet 2024 ·Toxicology and Applied Pharmacology ·(unknown), Christelle Douillet, Peter H. Cable, Sergey A. Krupenko, (unknown), Hadley J. Hartwell, Fei Zou, Beverly H. Koller, Rebecca C. Fry, Fernando Pardo‐Manuel de Villena, Miroslav Stýblo	0
7	Human ACE2 expression, a major tropism determinant for SARS-CoV-2, is regulated by upstream and intragenic elements 2023 ·PLoS Pathogens ·John N. Snouwaert, Leigh A. Jania, Trang Thi Huyen Nguyen, David R. Martinez, Alexandra Schäfer, Nicholas Catanzaro, Kendra L. Gully, Ralph S. Baric, Mark T. Heise, Martin T. Ferris, Elizabeth J. Anderson, (unknown), (unknown), Sharon Taft-Benz, Victoria K. Baxter, Jenny P.‐Y. Ting, Beverly H. Koller	9
8	Cell‐Specific Actions of the Prostaglandin E‐Prostanoid Receptor 4 Attenuating Hypertension: A Dominant Role for Kidney Epithelial Cells Compared With Macrophages 2022 ·Journal of the American Heart Association ·Ting Yang, Chengcheng Song, Donna L. Ralph, (unknown), Matthew A. Sparks, Beverly H. Koller, Alicia A. McDonough, Thomas M. Coffman	3
9	Platelet-activating factor (PAF) mediates NLRP3-NEK7 inflammasome induction independently of PAFR 2019 ·The Journal of Experimental Medicine ·Meng Deng, Haitao Guo, Jason W. Tam, Brandon M. Johnson, W. June Brickey, James S. New, (unknown), Hexin Shi, Douglas T. Golenbock, Beverly H. Koller, Karen P. McKinnon, Bruce Beutler, Jenny P.‐Y. Ting	43
10	Beyond detoxification: Pleiotropic functions of multiple glutathione S-transferase isoforms protect mice against a toxic electrophile 2019 ·PLoS ONE ·(unknown), Leigh A. Jania, John N. Snouwaert, MyTrang Nguyen, Sheryl S. Moy, Andrey P. Tikunov, Jeffrey M. Macdonald, Beverly H. Koller	18
11	Lipopolysaccharide Potentiates Insulin-Driven Hypoglycemic Shock 2017 ·The Journal of Immunology ·Jon A. Hagar, Matthew L. Edin, Fred B. Lih, Lance R. Thurlow, Beverly H. Koller, Bruce A. Cairns, Darryl C. Zeldin, Edward A. Miao	18
12	Neuronal NLRP1 inflammasome activation of Caspase-1 coordinately regulates inflammatory interleukin-1-beta production and axonal degeneration-associated Caspase-6 activation. 2015 ·PMC ·Vandana Kaushal, (unknown), Prateep Pakavathkumar, Bénédicte Foveau, Joseph Flores, Bradley T. Hyman, Bernardino Ghetti, Beverly H. Koller, Andréa C. LeBlanc	4
13	Effects of the selective kainate receptor antagonist ACET on altered sensorimotor gating in a genetic model of reduced NMDA receptor function 2012 ·Brain Research ·Gary E. Duncan, Beverly H. Koller, Sheryl S. Moy	7
14	Coupling of COX-1 to mPGES1 for prostaglandin E2 biosynthesis in the murine mammary gland 2005 ·Journal of Lipid Research ·Subhashini Chandrasekharan, N.A. Foley, Leigh A. Jania, Patsy Clark, Laurent Audoly, Beverly H. Koller	23
15	Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo 2002 ·Journal of Clinical Investigation ·J Fabre, Jennifer L. Goulet, Estelle Riche, MyTrang Nguyen, Kenneth Coggins, Steven Offenbacher, Beverly H. Koller	57
16	Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo 2002 ·Journal of Clinical Investigation ·J Fabre, Jennifer L. Goulet, Estelle Riche, MyTrang Nguyen, Kenneth Coggins, Steven Offenbacher, Beverly H. Koller	5
17	Immune Responses in 4-1BB (CD137)-Deficient Mice 2002 ·The Journal of Immunology ·Byoung S. Kwon, (unknown), (unknown), (unknown), Su K. Seo, Beom K. Choi, Beverly H. Koller, Godwin O. Wolisi, Hal E. Broxmeyer, Dass S. Vinay	186
18	Deficiency of 5-Lipoxygenase Accelerates Renal Allograft Rejection in Mice 2001 ·The Journal of Immunology ·Jennifer L. Goulet, Robert Griffiths, Phillip Ruiz, Roslyn B. Mannon, (unknown), Jeffrey L. Platt, Beverly H. Koller, Thomas M. Coffman	25
19	Genetic Factors Determine the Contribution of Leukotrienes to Acute Inflammatory Responses 2000 ·The Journal of Immunology ·Jennifer L. Goulet, Robert S. Byrum, (unknown), MyTrang Nguyen, (unknown), Beverly H. Koller	23
20	A Murine Model of Cystic Fibrosis 1995 ·American Journal of Respiratory and Critical Care Medicine ·John N. Snouwaert, (unknown), Anne M. Latour, (unknown), Ute Schwab, Matthew Ian Gilmour, Beverly H. Koller	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact